Literature DB >> 23332386

The feasibility of using SMS as a health survey tool: an exploratory study in patients with rheumatoid arthritis.

Sharon Song Song Lee1, Xiaohui Xin, Wan Pin Lee, Eugene Junying Sim, Benedict Tan, Michael Philip Geroche Bien, Alexander See Tiung Lau, Julian Thumboo.   

Abstract

AIM: To explore the feasibility of using SMS to conduct health surveys in patients with rheumatoid arthritis (RA).
METHODS: Using a two-way SMS system, we conducted a baseline survey using a short and a long quality of life instrument, with two follow-up administrations of the short survey among patients with RA on follow-up at the Singapore General Hospital (SGH). Our outcome variables were survey response rate, question response time, proportion of replies following the format instructions, and survey administration cost.
RESULTS: Among 85 participants (of 99 eligible patients approached), the response rate was 67% for the long survey, 80% for the short survey at baseline, and 74% and 70% at the first and second follow-ups, respectively. Survey response rate varied with the employment status of respondents. Approximately 78% of all replies followed the format instructions. All these replies were received within the stipulated 24-h timeline and half of them were received within 29 min. Response time for the other 22% of replies that did not follow the format instructions was much longer. The average administration cost per survey was S$0.34 (equivalent of US$0.26).
CONCLUSIONS: Two-way SMS is a promising tool to conduct short health surveys. Evidence for implementing long surveys over SMS is still weak. The post survey interviews with survey participants suggested that sequential delivery of survey questions coupled with SMS reminders in the interim, tailoring survey questions to individual health conditions, and providing feedback on individual survey results can potentially improve the response rate of such surveys.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23332386     DOI: 10.1016/j.ijmedinf.2012.12.003

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  6 in total

1.  Governance strategies for conducting text messaging interventions in clinical research.

Authors:  Nicholas Anderson; Caitlin Morrison; Jonathan Griffin; William Reiter; Laura-Mae Baldwin; Kelly Edwards
Journal:  Clin Transl Sci       Date:  2014-04       Impact factor: 4.689

2.  Feasibility, acceptability and validity of SMS text messaging for measuring change in depression during a randomised controlled trial.

Authors:  Stewart J Richmond; Ada Keding; Magdalene Hover; Rhian Gabe; Ben Cross; David Torgerson; Hugh MacPherson
Journal:  BMC Psychiatry       Date:  2015-04-03       Impact factor: 3.630

Review 3.  The Technological Growth in eHealth Services.

Authors:  Shilpa Srivastava; Millie Pant; Ajith Abraham; Namrata Agrawal
Journal:  Comput Math Methods Med       Date:  2015-06-03       Impact factor: 2.238

4.  Attributes and circumstances that induce inappropriate health services demand: a study of the health sector in Brazil.

Authors:  Djalma S Guimarães; Eduardo J O Soares; Gileno Ferraz Júnior; Denise D Medeiros
Journal:  BMC Health Serv Res       Date:  2015-02-18       Impact factor: 2.655

5.  Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Message Surveys in African-American Young Adults Experiencing Homelessness and Unemployment: Single-Group Study.

Authors:  Larissa Jennings Mayo-Wilson; Nancy E Glass; Alain Labrique; Melissa Davoust; Fred M Ssewamala; Sebastian Linnemayr; Matthew W Johnson
Journal:  JMIR Form Res       Date:  2020-07-17

Review 6.  The role of interdisciplinary research team in the impact of health apps in health and computer science publications: a systematic review.

Authors:  Guillermo Molina Recio; Laura García-Hernández; Rafael Molina Luque; Lorenzo Salas-Morera
Journal:  Biomed Eng Online       Date:  2016-07-15       Impact factor: 2.819

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.